Disseminate and Recurrent Infundibular Folliculitis
- Author: Stephen W White, MD; Chief Editor: Dirk M Elston, MD more...
Background
Disseminate and recurrent infundibular folliculitis (DRIF) was first described in 1968 by Hitch and Lund.[1] The clinical presentation is much like miliaria or keratosis pilaris. It is mostly seen in young healthy people, and most patients have a dark skin color. It consists of generalized flesh-colored papules. Therapy has generally been unsuccessful.
Courtesy of San Antonio Uniformed Services Health Education Consortium slide files. The validity of disseminate and recurrent infundibular folliculitis as a separate entity has been questioned. However, it does have such a characteristic clinical picture that for the present it is accepted as an entity.
Pathophysiology
The etiology of disseminate and recurrent infundibular folliculitis is not established.
Epidemiology
Frequency
United States
Although the first case of disseminate and recurrent infundibular folliculitis was not reported until 1968, other more recent reports indicate that it is a fairly common occurrence. Clinics that see a large number of young dark-skinned patients report that disseminate and recurrent infundibular folliculitis is a common condition. Indeed, it may occur in large numbers in hot, humid weather.
International
Cases of disseminate and recurrent infundibular folliculitis have been reported from Europe and India.
Mortality/Morbidity
Pruritus is the troublesome symptom of disseminate and recurrent infundibular folliculitis. In the past, this was difficult to relieve. The condition may be recurrent over a number of years. Disseminate and recurrent infundibular folliculitis may make it uncomfortable for the patient to work in a hot, humid environment.
Race
Disseminate and recurrent infundibular folliculitis has been reported primarily in people of African American origin in the United States.[2] Why a number of dermatoses tend to be papular and follicular in dark-skinned people is not known. This phenomenon is well documented in atopic dermatitis.
Sex
Although most of the patients are men, disseminate and recurrent infundibular folliculitis has been reported in women.
Age
Most of the reported disseminate and recurrent infundibular folliculitis patients have been healthy young adults.
Hitch JM, Lund HZ. Disseminate and recurrent infundibulo-folliculitis: report of a case. Arch Dermatol. Apr 1968;97(4):432-5. [Medline].
Barriere H, Litoux P, Bureau B, Stalder JF. [Disseminate and recurrent infundibulo-folliculitis (Hitch and Lund)]. Ann Dermatol Venereol. Apr 1980;107(4):299-302. [Medline].
Hinds GA, Heald PW. A case of disseminate and recurrent infundibulofolliculitis responsive to treatment with topical steroids. Dermatol Online J. Nov 15 2008;14(11):11. [Medline].
Ravikumar BC, Balachandran C, Shenoi SD, Sabitha L, Ramnarayan K. Disseminate and recurrent infundibulofolliculitis: response to psoralen plus UVA therapy. Int J Dermatol. Jan 1999;38(1):75-6. [Medline].
Aroni K, Grapsa A, Agapitos E. Disseminate and recurrent infundibulofolliculitis: response to isotretinoin. J Drugs Dermatol. Jul-Aug 2004;3(4):434-5. [Medline].
Owen WR, Wood C. Disseminate and recurrent infundibulofolliculitis. Arch Dermatol. Feb 1979;115(2):174-5. [Medline].
El Shabrawi-Caelen L, Soyer HP. Clinical Pathologic Challenge: Patchy pityriasiform lichenoid eczema. Am J Dermatopathol. Jun 2005;27(3):216, 258.
White SW, Rodman OG. Disseminate and recurrent infundibulofolliculitis. J Assoc Military Dermatol. 1981;22-23.

